Erratum: Targeting IDH1 as a prosenescent therapy in high-grade serous ovarian cancer (Molecular Cancer Research (2019) 17 (1710-1720) DOI: 10.1158/1541-7786)

E. S. Dahl, R. Buj, K. E. Leon, J. M. Newell, Y. Imamura, B. G. Bitler

Research output: Contribution to journalComment/debatepeer-review

Abstract

In the original version of this article (1), Ovcar3 cell line data in Fig. 2D was a duplicate of the Ovcar10 cell line data. This duplication was inadvertent and does not affect the main conclusions of the study. The graph for Ovcar3 has been corrected in the latest online HTML and PDF versions of the article. The authors regret this error.

Original languageEnglish (US)
Pages (from-to)797
Number of pages1
JournalMolecular Cancer Research
Volume18
Issue number5
DOIs
StatePublished - May 1 2020

All Science Journal Classification (ASJC) codes

  • Molecular Biology
  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Erratum: Targeting IDH1 as a prosenescent therapy in high-grade serous ovarian cancer (Molecular Cancer Research (2019) 17 (1710-1720) DOI: 10.1158/1541-7786)'. Together they form a unique fingerprint.

Cite this